Dhampur Bio Organics Limited disclosed on April 06, 2026, that its promoters and persons acting in concert did not create any encumbrance on equity shares during the financial year 2025-26. The declaration, submitted by Gautam Goel on behalf of the promoter group, confirms that no shares were pledged directly or indirectly other than those previously disclosed. This compliance filing was made to the stock exchanges pursuant to Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011.

The submission provides assurance to shareholders regarding the financial standing of the promoter group as of March 31, 2026. The disclosure was formally addressed to the listing departments of BSE Limited and National Stock Exchange of India Ltd. by Company Secretary & Compliance Officer Ashu Rawat.

The filing encompasses a comprehensive list of individuals and entities within the promoter and promoter group. The list includes 45 names, ranging from individuals such as Vijay Kumar Goel and Deepa Goel to corporate entities like Shudh Edible Products Private Limited and Sonitron Limited.

Promoter and Promoter Group Details

The following table outlines the members of the promoter and promoter group who are party to the declaration:

Dhampur Bio Organics Limited reported a consolidated net profit of ₹25.18 crore for the financial year ended March 31, 2026, driven by higher income from operations. The company's revenue from operations for the year stood at ₹3,133.41 crore, compared to ₹2,696.64 crore in the previous year. For the quarter ended March 31, 2026, the consolidated net profit was ₹46.27 crore, while consolidated revenue from operations reached ₹781.41 crore.

The Board of Directors, at its meeting held on May 30, 2026, approved the audited standalone and consolidated financial results. The board recommended a final dividend of 15%, or ₹1.50 per share, amounting to ₹9.96 crore. The statutory auditors issued an audit report with an unmodified opinion on the financial results. The company noted that the Income Tax Department conducted a search at its premises from October 29, 2025, to November 04, 2025, but stated that no adjustments were required in the financial results regarding the outcome of the search.

Subsequent to the reporting date, the company entered into a Business Transfer Agreement on April 20, 2026, to sell its sugar manufacturing undertaking located at Meerganj, Bareilly, Uttar Pradesh, for an aggregate consideration of ₹305.00 crore. This sale was approved by shareholders in an EGM held on May 18, 2026, and is expected to be completed within 60 days from the execution of the agreement.

Q4 Standalone Performance

On a standalone basis, Dhampur Bio Organics posted Q4 net profit of ₹46.00 crore, compared to ₹39.65 crore in the same period last year. Q4 standalone revenue came in at ₹793.45 crore versus ₹703.57 crore year-on-year. The following table summarises the key standalone Q4 metrics:

While revenue and net profit improved year-on-year, EBITDA declined to ₹95.30 crore from ₹98.50 crore, with the EBITDA margin contracting to 12.13% from 14.03% in the corresponding period of the previous year, indicating higher operating costs relative to revenue.

Standalone Financial Results (FY26)

Consolidated Financial Results (FY26)